Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.
Search the Roll Call archive by keyword, date, Congress, section, or tags.
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.
Congress is on the verge of allowing the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift costs to the private market.
Christopher S. Murphy, D-Conn., said his colleague Sen.
Federal officials plan to begin shipping thousands of doses of the monoclonal antibody drug used to treat President Trump, but while he promised it would be widely available for free, limited manufacturing may leave the drug from Regeneron Pharmaceuticals out of reach for most patients battling the coronavirus.
Medical treatments hailed by Trump in the fight against COVID-19 include Regeneron’s monoclonal antibody treatment, which is not available to the public.
The departing inspector general, former federal prosecutor Scott S. Dahl, emphasized in his Tuesday statement that any conflicts did not play a part in his retirement.
But he was excluded from a subsequent COVID-19 meeting and was told it was because he had offended Azar and started a “s— storm.”
Christopher S.
The $100 billion for hospitals in the bill (S 3548) — almost a third of the package — would provide reimbursement to cover health care expenses and lost revenue due to the outbreak of COVID-19.